[ Price : $8.95]
FDA accepts for priority review a Novartis supplemental NDA for Scemblix (asciminib) for the drugs expanded use in treating newly ...[ Price : $8.95]
Federal Register notice: FDA renews its Pharmacy Compounding Advisory Committee for an additional two years.[ Price : $8.95]
Federal Register notice: FDA withdraws approval of 23 ANDAs from multiple applicants after they notified the agency that the produ...[ Price : $8.95]
AstraZeneca says data from its Phase 3 AMPLIFY trial showed that Calquence (acalabrutinib) in combination with venetoclax showed f...[ Price : $8.95]
FDA cites a Kaleo social media post about Auvi-Q (epinephrine injection) because it presented benefit information but failed to in...[ Price : $8.95]
FDA issues Carie Boyd Pharmaceuticals a six-observation Form FDA-483 after inspecting the firms Irving,TX outsourcing facility las...[ Price : $8.95]
FDA approves an Alpha Cognition NDA for ZUNVEYL (benzgalantamine) for treating mild-to-moderate Alzheimers disease.[ Price : $8.95]
FDA grants Elixir Medical a breakthrough device designation for its DynamX Sirolimus-Eluting Coronary Bioadaptor System for use in...